jeudi 4 juin 2015

Onco Actu du 4 juin 2015

1. Biologie

CRISPR, the disruptor [Nature News & Comment]

4.1 Dép., diag. & prono. - Prostate

NICE issues final diagnostics guidance on prostate cancer tests and consults on draft guidance on tests for bacterial infection and skin cancer [NICE]

New Tests to Improve Decision Making in Prostate Cancer Treatment [CANCER RESEARCH Catalyst]

Misinformation from NY-Presbyterian about a new prostate cancer test [HealthNewsReview]

4.2 Dép., diag. & prono. - Génome

Clinical Sequencing Data Sharing Is Essential [MassGenomics]

4.9 Dép., diag. & prono. - Sein

International Group Says Mammograms Of 'Limited' Value For Women In 40s [NPR]

Benefits of mammography screening outweigh adverse effects for women aged 50–69 years [IARC]

Breast cancer screening cuts chance of dying from disease by 40%, say experts [The Guardian]

Breast cancer screening cuts deaths by 40% [The Telegraph]

5.2 Pharma

Roche maintains dominance as leading cancer drugmaker [PMLiVE]

5.2.1 Pharma - Partenariats

Merck & Co. Extends $100M+ Agenus Cancer Collaboration [GEN]

Celgene, Bluebird Streamline CAR-T Partnership To Fight Myeloma [Xconomy]

Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA [Bluebird Bio]

5.2.3 Pharma - économie

Business: The billion-dollar biotech [Nature News & Comment]

AZ's Soriot lashes out at U.K.'s refusal to pay for first-in-class cancer drug [FiercePharma]

Soon-Shiong raises $75M for another oncology player in his murky empire [FierceBiotech]

5.3 Traitements - FDA, EMA,...

Cancer Drugs First to Take Advantage of UK Early Access Scheme [RAPS]

5.4 Traitements - Economie

NICE recommends VARGATEF® (nintedanib*) in combination with docetaxel as an option for patients with non-small cell lung cancer of adenocarcinoma histology within its licensed indication [Boehringer Ingelheim]

5.5.13 ASCO (divers)

Fitness program shows significant gains for cancer survivor participants [Dana-Farber Cancer Institute]

5.6 ESMO

Josep Tabernero´s candidacy for presidency of the European Society for Medical Oncology and an invitation to ESMO Members to cast their votes before Monday 15 June 2015 [Vall d'Hebron Institute of Oncology]

6. Lutte contre les cancers

Selling Hope: How the Business of Cancer Is Taking Off in China [Bloomberg]

Teenagers and young adults with cancer - addressing the most important care needs [Cancer World]

6.6 Publications

Justifying conflicts of interest in medical journals: a very bad idea [BMJ]

Former NEJM editors slam "backtrack" on conflict of interest [HealthNewsReview]

6.7.2 Applis

BaseHealth Releases Genomic Data API for Precision Health Apps [ProgrammableWeb]

6.9 Controverses

'The Censor's Hand' [InsideHigherEd]